Indeed, paclitaxel-induced tubulin polymerization was shown to stimulate GLUT1-dependent hexose uptake in C6 glioma cells, thereby suggesting that metabolic reprogramming towards glycolysis may be a direct consequence of NAC treatment. The gene discussed is SLC2A1; the disease is central nervous system cancer.